新生學校財團法人新生醫護管理專科學校圖書館 |

Global health partnerships = the pharmaceutical industry and BRICA /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Global health partnerships/ Mei-Ling Wang.
Reminder of title:	the pharmaceutical industry and BRICA /
Author:	Wang, Mei-Ling,
Published:	Basingstoke [England] ;Palgrave Macmillan, : 2009.,
Description:	1 online resource (x, 193 p.)
Notes:	Description based on print version record.
Subject:	Pharmaceutical policy. -
Online resource:	access to fulltext (Palgrave)
ISBN:	9780230582873 (electronic bk.)

Global health partnerships = the pharmaceutical industry and BRICA /
Wang, Mei-Ling,1960-

Global health partnershipsthe pharmaceutical industry and BRICA /[electronic resource] :Mei-Ling Wang. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (x, 193 p.)

Description based on print version record.

Includes bibliographical references (p. 167-187) and index.

Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.

The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.

ISBN: 9780230582873 (electronic bk.)

Standard No.: 10.1057/9780230582873doiSubjects--Topical Terms:

231641
Pharmaceutical policy.
Index Terms--Genre/Form:

96803
Electronic books.

LC Class. No.: RA401.A1 / W36 2009eb

Dewey Class. No.: 362.17/82

Global health partnerships = the pharmaceutical industry and BRICA /
LDR:02477cmm 2200301Ia 4500 001 158551
003 OCoLC
005 20100709081737.0
006 m d
007 cr cnu---unuuu
008 160219s2009 enk sb 001 0 eng d
020 $a 9780230582873 (electronic bk.)
020 $a 0230582877 (electronic bk.)
024 7 $a 10.1057/9780230582873 $2 doi
035 $a (OCoLC)314821483
035 $a ocn314821483
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N $d EBLCP
049 $a APTA
050 4 $a RA401.A1 $b W36 2009eb
082 0 4 $a 362.17/82 $2 22
100 1 $a Wang, Mei-Ling, $d 1960- $3 305012
245 1 0 $a Global health partnerships $h [electronic resource] : $b the pharmaceutical industry and BRICA / $c Mei-Ling Wang.
260 $a Basingstoke [England] ; $a New York : $c 2009. $b Palgrave Macmillan,
300 $a 1 online resource (x, 193 p.)
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 167-187) and index.
505 0 $a Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.
520 $a The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.
650 0 $a Pharmaceutical policy. $3 231641
650 0 $a World health. $3 99087
650 0 $a Public health $x International cooperation. $3 99088
650 0 $a Pharmaceutical industry. $3 90281
655 7 $a Electronic books. $2 local. $3 96803
776 0 8 $i Print version: $a Wang, Mei-Ling, 1960- $t Global health partnerships. $d Basingstoke [England] ; New York : Palgrave Macmillan, 2009 $z 9780230515604 $w (DLC) 2008041055 $w (OCoLC)144227166
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9780230582873 $z access to fulltext (Palgrave)